-+ 0.00%
-+ 0.00%
-+ 0.00%

Nurix CSO Gwenn Hansen disposes of 1,452 common shares worth $36,982.44

PUBT·09/01/2026 21:19:58
Listen to the news
Nurix CSO Gwenn Hansen disposes of 1,452 common shares worth $36,982.44
  • Nurix Therapeutics Chief Scientific Officer Gwenn Hansen exercised employee stock options for 1,452 shares at USD 1.86 on Sept. 1, 2026.
  • Hansen sold 1,452 shares at USD 25.47 the same day.
  • Directly held common stock ended at 117,227 shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nurix Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001817160-26-000019), on September 01, 2026, and is solely responsible for the information contained therein.